Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimers Dement

Retrieve available abstracts of 408 articles:
HTML format



Single Articles


    July 2021
  1. GARNIER-CRUSSARD A, Bougacha S, Wirth M, Dautricourt S, et al
    White matter hyperintensity topography in Alzheimer's disease and links to cognition.
    Alzheimers Dement. 2021 Jul 28. doi: 10.1002/alz.12410.
    PubMed     Abstract available


  2. BOADA M, Rodrigo A, Jessen F, Wimblad B, et al
    Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12441.
    PubMed     Abstract available


  3. HOSCHEIDT S, Sanderlin AH, Baker LD, Jung Y, et al
    Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12421.
    PubMed     Abstract available


  4. VAN HARTEN AC, Wiste HJ, Weigand SD, Mielke MM, et al
    Detection of Alzheimer's disease amyloid beta 1-42, p-tau, and t-tau assays.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12406.
    PubMed     Abstract available


  5. KULMINSKI AM, Philipp I, Loika Y, He L, et al
    Protective association of the epsilon2/epsilon3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men.
    Alzheimers Dement. 2021 Jul 26. doi: 10.1002/alz.12413.
    PubMed     Abstract available


  6. BOCHE D, Gordon MN
    Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease.
    Alzheimers Dement. 2021 Jul 5. doi: 10.1002/alz.12389.
    PubMed     Abstract available


    June 2021
  7. ZHANG X, Farrell JJ, Tong T, Hu J, et al
    Association of mitochondrial variants and haplogroups identified by whole exome sequencing with Alzheimer's disease.
    Alzheimers Dement. 2021 Jun 20. doi: 10.1002/alz.12396.
    PubMed     Abstract available


  8. TEERLINK CC, Miller JB, Vance EL, Staley LA, et al
    Analysis of high-risk pedigrees identifies 12 candidate variants for Alzheimer's disease.
    Alzheimers Dement. 2021 Jun 20. doi: 10.1002/alz.12397.
    PubMed     Abstract available


  9. ZHONG W, Wu A, Berglund K, Gu X, et al
    Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A.
    Alzheimers Dement. 2021 Jun 20. doi: 10.1002/alz.12398.
    PubMed     Abstract available


  10. JANELIDZE S, Palmqvist S, Leuzy A, Stomrud E, et al
    Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Abeta42/Abeta40 and p-tau.
    Alzheimers Dement. 2021 Jun 20. doi: 10.1002/alz.12395.
    PubMed     Abstract available


  11. BIRKENBIHL C, Salimi Y, Frohlich H
    Unraveling the heterogeneity in Alzheimer's disease progression across multiple cohorts and the implications for data-driven disease modeling.
    Alzheimers Dement. 2021 Jun 9. doi: 10.1002/alz.12387.
    PubMed     Abstract available


  12. LOPEZ-RODRIGUEZ AB, Hennessy E, Murray CL, Nazmi A, et al
    Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL-1beta drives amplified responses in primed astrocytes and neuronal network dysfunction.
    Alzheimers Dement. 2021 Jun 3. doi: 10.1002/alz.12341.
    PubMed     Abstract available


  13. TEMP AGM, Lutz MW, Trepel D, Tang Y, et al
    How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer's disease.
    Alzheimers Dement. 2021;17:917-919.
    PubMed    


  14. FRANZMEIER N, Ossenkoppele R, Brendel M, Rubinski A, et al
    The BIN1 rs744373 Alzheimer's disease risk SNP is associated with faster Abeta-associated tau accumulation and cognitive decline.
    Alzheimers Dement. 2021 Jun 1. doi: 10.1002/alz.12371.
    PubMed     Abstract available


  15. RICHARD E, den Brok MGHE, van Gool WA
    Bayes analysis supports null hypothesis of anti-amyloid beta therapy in Alzheimer's disease.
    Alzheimers Dement. 2021;17:1051-1055.
    PubMed     Abstract available


  16. DE ERAUSQUIN GA, Snyder H, Carrillo M, Hosseini AA, et al
    The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning.
    Alzheimers Dement. 2021;17:1056-1065.
    PubMed     Abstract available


    May 2021
  17. SEXTON CE, Anstey KJ, Baldacci F, Barnum CJ, et al
    Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney.
    Alzheimers Dement. 2021 May 31. doi: 10.1002/alz.12380.
    PubMed     Abstract available


  18. O'BRYANT SE, Zhang F, Petersen M, Hall JR, et al
    A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research.
    Alzheimers Dement. 2021 May 31. doi: 10.1002/alz.12382.
    PubMed     Abstract available


  19. PANNUZZO M
    Beta-amyloid pore linked to controlled calcium influx into the cell: A new paradigm for Alzheimer's Disease.
    Alzheimers Dement. 2021 May 29. doi: 10.1002/alz.12373.
    PubMed     Abstract available


  20. SCHWAHN C, Frenzel S, Holtfreter B, Van der Auwera S, et al
    Effect of periodontal treatment on preclinical Alzheimer's disease-Results of a trial emulation approach.
    Alzheimers Dement. 2021 May 29. doi: 10.1002/alz.12378.
    PubMed     Abstract available


  21. RAJAN KB, Weuve J, Barnes LL, McAninch EA, et al
    Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060).
    Alzheimers Dement. 2021 May 27. doi: 10.1002/alz.12362.
    PubMed     Abstract available


  22. HAMPEL H, Shaw LM, Aisen P, Chen C, et al
    State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease.
    Alzheimers Dement. 2021 May 27. doi: 10.1002/alz.12372.
    PubMed     Abstract available


  23. JIANG Y, Zhou X, Ip FC, Chan P, et al
    Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging.
    Alzheimers Dement. 2021 May 25. doi: 10.1002/alz.12369.
    PubMed     Abstract available


  24. APOSTOLOVA LG, Aisen P, Eloyan A, Fagan A, et al
    The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology.
    Alzheimers Dement. 2021 May 21. doi: 10.1002/alz.12350.
    PubMed     Abstract available


  25. STERN Y, Stallard E, Kinosian B, Zhu C, et al
    Validation and demonstration of a new comprehensive model of Alzheimer's disease progression.
    Alzheimers Dement. 2021 May 14. doi: 10.1002/alz.12336.
    PubMed     Abstract available


  26. HONG S, Dobricic V, Ohlei O, Bos I, et al
    TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
    Alzheimers Dement. 2021 May 14. doi: 10.1002/alz.12330.
    PubMed     Abstract available


  27. LIBIGER O, Shaw LM, Watson MH, Nairn AC, et al
    Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease.
    Alzheimers Dement. 2021 May 13. doi: 10.1002/alz.12353.
    PubMed     Abstract available


  28. GUSTAVSSON A, Raket LL, Lilja M, Rutten-Jacobs L, et al
    Health utility in preclinical and prodromal Alzheimer's disease for establishing the value of new disease-modifying treatments-EQ-5D data from the Swedish BioFINDER study.
    Alzheimers Dement. 2021 May 13. doi: 10.1002/alz.12355.
    PubMed     Abstract available


  29. MORGAN DG, Mielke MM
    Knowledge gaps in Alzheimer's disease immune biomarker research.
    Alzheimers Dement. 2021 May 13. doi: 10.1002/alz.12342.
    PubMed     Abstract available


  30. OSSENKOPPELE R, Hansson O
    Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease.
    Alzheimers Dement. 2021 May 13. doi: 10.1002/alz.12356.
    PubMed     Abstract available


  31. MADRASI K, Das R, Mohmmadabdul H, Lin L, et al
    Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease.
    Alzheimers Dement. 2021 May 2. doi: 10.1002/alz.12312.
    PubMed     Abstract available



  32. Association commits $14 million to novel drug trials in rare form of Alzheimer's.
    Alzheimers Dement. 2021;17:910.
    PubMed    


    April 2021
  33. RANASINGHE KG, Petersen C, Kudo K, Mizuiri D, et al
    Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early-onset and atypical Alzheimer's disease.
    Alzheimers Dement. 2021 Apr 21. doi: 10.1002/alz.12349.
    PubMed     Abstract available


  34. LI X, Tsolis KC, Koper MJ, Ronisz A, et al
    Sequence of proteome profiles in preclinical and symptomatic Alzheimer's disease.
    Alzheimers Dement. 2021 Apr 19. doi: 10.1002/alz.12345.
    PubMed     Abstract available


  35. BABILONI C, Arakaki X, Azami H, Bennys K, et al
    Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel.
    Alzheimers Dement. 2021 Apr 15. doi: 10.1002/alz.12311.
    PubMed     Abstract available


  36. MOELLER S, Sridhar J, Martersteck A, Coventry C, et al
    Functional decline in the aphasic variant of Alzheimer's disease.
    Alzheimers Dement. 2021 Apr 8. doi: 10.1002/alz.12331.
    PubMed     Abstract available


  37. MOLONEY CM, Lowe VJ, Murray ME
    Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.
    Alzheimers Dement. 2021 Apr 2. doi: 10.1002/alz.12321.
    PubMed     Abstract available


  38. PROKOPENKO D, Morgan SL, Mullin K, Hofmann O, et al
    Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development.
    Alzheimers Dement. 2021 Apr 2. doi: 10.1002/alz.12319.
    PubMed     Abstract available


  39. SABBAGH MN, Cummings J
    Open Peer Commentary to "Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019".
    Alzheimers Dement. 2021;17:702-703.
    PubMed    


    March 2021
  40. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Plasma P-tau181 to Abeta42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12332.
    PubMed     Abstract available


  41. SHI L, Winchester LM, Westwood S, Baird AL, et al
    Replication study of plasma proteins relating to Alzheimer's pathology.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12322.
    PubMed     Abstract available


  42. HANSSON O, Batrla R, Brix B, Carrillo MC, et al
    The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid beta and tau.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12316.
    PubMed     Abstract available



  43. Register for May AAIC(R) Satellite Symposium and second Latinos & Alzheimer's symposium.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12337.
    PubMed    


  44. AKHTER-KHAN SC, Tao Q, Ang TFA, Itchapurapu IS, et al
    Associations of loneliness with risk of Alzheimer's disease dementia in the Framingham Heart Study.
    Alzheimers Dement. 2021 Mar 24. doi: 10.1002/alz.12327.
    PubMed     Abstract available



  45. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2021 Mar 23. doi: 10.1002/alz.12328.
    PubMed     Abstract available


  46. BECKMAN D, Chakrabarty P, Ott S, Dao A, et al
    A novel tau-based rhesus monkey model of Alzheimer's pathogenesis.
    Alzheimers Dement. 2021 Mar 18. doi: 10.1002/alz.12318.
    PubMed     Abstract available


  47. KOCIOLEK AJ, Fernandez KK, Jin Z, Cosentino S, et al
    Extrapyramidal signs and Alzheimer's disease prognosis in a multiethnic, community-based sample of demented elders.
    Alzheimers Dement. 2021 Mar 12. doi: 10.1002/alz.12309.
    PubMed     Abstract available


  48. DISBROW E, Stokes KY, Ledbetter C, Patterson J, et al
    Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2021 Mar 12. doi: 10.1002/alz.12305.
    PubMed     Abstract available


  49. FALGAS N, Walsh CM, Neylan TC, Grinberg LT, et al
    Deepen into sleep and wake patterns across Alzheimer's disease phenotypes.
    Alzheimers Dement. 2021 Mar 12. doi: 10.1002/alz.12304.
    PubMed     Abstract available


  50. RAHMAN M, White EM, Mills C, Thomas KS, et al
    Rural-urban differences in diagnostic incidence and prevalence of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2021 Mar 4. doi: 10.1002/alz.12285.
    PubMed     Abstract available


  51. SALVADO G, Mila-Aloma M, Shekari M, Minguillon C, et al
    Cerebral amyloid-beta load is associated with neurodegeneration and gliosis: Mediation by p-tau and interactions with risk factors early in the Alzheimer's continuum.
    Alzheimers Dement. 2021 Mar 4. doi: 10.1002/alz.12245.
    PubMed     Abstract available


  52. TURNER DA, Degan S, Hoffmann U, Galeffi F, et al
    CVN-AD Alzheimer's mice show premature reduction in neurovascular coupling in response to spreading depression and anoxia compared to aged controls.
    Alzheimers Dement. 2021 Mar 3. doi: 10.1002/alz.12289.
    PubMed     Abstract available


  53. MASEREJIAN N, Krzywy H, Eaton S, Galvin JE, et al
    Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis.
    Alzheimers Dement. 2021 Mar 3. doi: 10.1002/alz.12280.
    PubMed     Abstract available


  54. SAITO ER, Miller JB, Harari O, Cruchaga C, et al
    Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expression.
    Alzheimers Dement. 2021 Mar 2. doi: 10.1002/alz.12310.
    PubMed     Abstract available


    February 2021
  55. ASHFORD MT, Veitch DP, Neuhaus J, Nosheny RL, et al
    The search for a convenient procedure to detect one of the earliest signs of Alzheimer's disease: A systematic review of the prediction of brain amyloid status.
    Alzheimers Dement. 2021 Feb 13. doi: 10.1002/alz.12253.
    PubMed     Abstract available


  56. BRICKMAN AM, Manly JJ, Honig LS, Sanchez D, et al
    Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.
    Alzheimers Dement. 2021 Feb 13. doi: 10.1002/alz.12301.
    PubMed     Abstract available


  57. IZZO NJ, Yuede CM, LaBarbera KM, Limegrover CS, et al
    Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
    Alzheimers Dement. 2021 Feb 8. doi: 10.1002/alz.12302.
    PubMed     Abstract available


  58. BLEILE L
    Alzheimer's Association Update.
    Alzheimers Dement. 2021 Feb 4. doi: 10.1002/alz.12306.
    PubMed    


  59. WANG R, Qiu C, Dintica CS, Shang Y, et al
    Shared risk and protective factors between Alzheimer's disease and ischemic stroke: A population-based longitudinal study.
    Alzheimers Dement. 2021 Feb 1. doi: 10.1002/alz.12203.
    PubMed     Abstract available


  60. GUZMAN-VELEZ E, Zetterberg H, Fox-Fuller JT, Vila-Castelar C, et al
    Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease.
    Alzheimers Dement. 2021 Feb 1. doi: 10.1002/alz.12248.
    PubMed     Abstract available


  61. GRISWOLD AJ, Celis K, Bussies PL, Rajabli F, et al
    Increased APOE epsilon4 expression is associated with the difference in Alzheimer's disease risk from diverse ancestral backgrounds.
    Alzheimers Dement. 2021 Feb 1. doi: 10.1002/alz.12287.
    PubMed     Abstract available


    January 2021
  62. AYTON S, Portbury S, Kalinowski P, Agarwal P, et al
    Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance.
    Alzheimers Dement. 2021 Jan 25. doi: 10.1002/alz.12282.
    PubMed     Abstract available


  63. SIMREN J, Leuzy A, Karikari TK, Hye A, et al
    The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.
    Alzheimers Dement. 2021 Jan 25. doi: 10.1002/alz.12283.
    PubMed     Abstract available


  64. GERMANN J, Elias GJB, Boutet A, Narang K, et al
    Brain structures and networks responsible for stimulation-induced memory flashbacks during forniceal deep brain stimulation for Alzheimer's disease.
    Alzheimers Dement. 2021 Jan 21. doi: 10.1002/alz.12238.
    PubMed     Abstract available


  65. BRYAN J, Mandan A, Kamat G, Gottschalk WK, et al
    Likelihood ratio statistics for gene set enrichment in Alzheimer's disease pathways.
    Alzheimers Dement. 2021 Jan 21. doi: 10.1002/alz.12223.
    PubMed     Abstract available


  66. LUCKETT PH, McCullough A, Gordon BA, Strain J, et al
    Modeling autosomal dominant Alzheimer's disease with machine learning.
    Alzheimers Dement. 2021 Jan 21. doi: 10.1002/alz.12259.
    PubMed     Abstract available


  67. LI HD, Funk CC, McFarland K, Dammer EB, et al
    Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease.
    Alzheimers Dement. 2021 Jan 21. doi: 10.1002/alz.12254.
    PubMed     Abstract available



  68. Alzheimer's Association International Conference Neuroscience Next focused on early career researchers across all of neuroscience.
    Alzheimers Dement. 2021;17:138-139.
    PubMed    


    December 2020
  69. VAN HULLE C, Jonaitis EM, Betthauser TJ, Batrla R, et al
    An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum.
    Alzheimers Dement. 2020 Dec 18. doi: 10.1002/alz.12204.
    PubMed     Abstract available


  70. LYSSENKO NN, Pratico D
    ABCA7 and the altered lipidostasis hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2020 Dec 17. doi: 10.1002/alz.12220.
    PubMed     Abstract available


  71. MOHAMMED H
    Recognizing African-American contributions to neurology: The role of Solomon Carter Fuller (1872-1953) in Alzheimer's disease research.
    Alzheimers Dement. 2020 Dec 15. doi: 10.1002/alz.12183.
    PubMed     Abstract available


  72. AUDRAIN M, Haure-Mirande JV, Mleczko J, Wang M, et al
    Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice.
    Alzheimers Dement. 2020 Dec 12. doi: 10.1002/alz.12256.
    PubMed     Abstract available


  73. KIM YW, Al-Ramahi I, Koire A, Wilson SJ, et al
    Harnessing the paradoxical phenotypes of APOE varepsilon2 and APOE varepsilon4 to identify genetic modifiers in Alzheimer's disease.
    Alzheimers Dement. 2020 Dec 7. doi: 10.1002/alz.12240.
    PubMed     Abstract available


  74. FRYE BM, Craft S, Register TC, Andrews RN, et al
    Diet, psychosocial stress, and Alzheimer's disease-related neuroanatomy in female nonhuman primates.
    Alzheimers Dement. 2020 Dec 3. doi: 10.1002/alz.12232.
    PubMed     Abstract available


    November 2020
  75. KARIKARI TK, Emersic A, Vrillon A, Lantero-Rodriguez J, et al
    Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.
    Alzheimers Dement. 2020 Nov 30. doi: 10.1002/alz.12236.
    PubMed     Abstract available


  76. LLIBRE-GUERRA JJ, Li Y, Allegri RF, Mendez PC, et al
    Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12227.
    PubMed     Abstract available


  77. DUENAS MR, Snyder PJ
    Alzheimer's team care approach-akin to diabetes-in the development, validation, and population assessment of retinal biomarkers for disease.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12234.
    PubMed     Abstract available


  78. SPENCER BE, Digma LA, Jennings RG, Brewer JB, et al
    Gene- and age-informed screening for preclinical Alzheimer's disease trials.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12207.
    PubMed     Abstract available


  79. HITHERSAY R, Baksh RA, Startin CM, Wijeratne P, et al
    Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12222.
    PubMed     Abstract available


  80. PENTZ R, Iulita MF, Ducatenzeiler A, Videla L, et al
    Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.
    Alzheimers Dement. 2020 Nov 23. doi: 10.1002/alz.12229.
    PubMed     Abstract available


  81. MONTAL V, Vilaplana E, Pegueroles J, Bejanin A, et al
    Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2020 Nov 16. doi: 10.1002/alz.12224.
    PubMed     Abstract available


  82. JESSEN F, Kleineidam L, Wolfsgruber S, Bickel H, et al
    Prediction of dementia of Alzheimer type by different types of subjective cognitive decline.
    Alzheimers Dement. 2020 Nov 2. doi: 10.1002/alz.12163.
    PubMed     Abstract available



  83. Alzheimer's Association pays tribute to former Chief Science Officer William (Bill) Thies, PhD.
    Alzheimers Dement. 2020;16:1600-1605.
    PubMed    


    October 2020
  84. SOHEILI-NEZHAD S, van der Linden RJ, Olde Rikkert M, Sprooten E, et al
    Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiology.
    Alzheimers Dement. 2020 Oct 19. doi: 10.1002/alz.12211.
    PubMed     Abstract available


  85. ARNSTEN AFT, Datta D, Tredici KD, Braak H, et al
    Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease.
    Alzheimers Dement. 2020 Oct 19. doi: 10.1002/alz.12192.
    PubMed     Abstract available


  86. WESSELS AM, Lines C, Stern RA, Kost J, et al
    Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.
    Alzheimers Dement. 2020 Oct 13. doi: 10.1002/alz.12164.
    PubMed     Abstract available


  87. MECCA AP, van Dyck CH
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
    Alzheimers Dement. 2020 Oct 12. doi: 10.1002/alz.12190.
    PubMed    


  88. SNYDER PJ, Alber J, Alt C, Bain LJ, et al
    Retinal imaging in Alzheimer's and neurodegenerative diseases.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12179.
    PubMed     Abstract available


  89. THUNELL J, Chen Y, Joyce G, Barthold D, et al
    Drug therapies for chronic conditions and risk of Alzheimer's disease and related dementias: A scoping review.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12175.
    PubMed     Abstract available


  90. JAIN S, Rosenbaum PR, Reiter JG, Hoffman G, et al
    Using Medicare claims in identifying Alzheimer's disease and related dementias.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12199.
    PubMed     Abstract available


  91. HOU X, Watzlawik JO, Cook C, Liu CC, et al
    Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12198.
    PubMed     Abstract available


  92. BUBU OM, Umasabor-Bubu OQ, Turner AD, Parekh A, et al
    Self-reported obstructive sleep apnea, amyloid and tau burden, and Alzheimer's disease time-dependent progression.
    Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12184.
    PubMed     Abstract available


    September 2020
  93. FRANCESCO DL, Koch G
    Synaptic impairment: The new battlefield of Alzheimer's disease.
    Alzheimers Dement. 2020 Sep 18. doi: 10.1002/alz.12189.
    PubMed    



  94. 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease.
    Alzheimers Dement. 2020 Sep 13. doi: 10.1002/alz.12172.
    PubMed     Abstract available


  95. JIA L, Xu H, Chen S, Wang X, et al
    The APOE epsilon4 exerts differential effects on familial and other subtypes of Alzheimer's disease.
    Alzheimers Dement. 2020 Sep 3. doi: 10.1002/alz.12153.
    PubMed     Abstract available


  96. DE LEON J, Grasso SM, Welch A, Miller Z, et al
    Effects of bilingualism on age at onset in two clinical Alzheimer's disease variants.
    Alzheimers Dement. 2020 Sep 3. doi: 10.1002/alz.12170.
    PubMed     Abstract available


    August 2020
  97. LIU CC, Yamazaki Y, Heckman MG, Martens YA, et al
    Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease.
    Alzheimers Dement. 2020 Aug 22. doi: 10.1002/alz.12104.
    PubMed     Abstract available


  98. FRISONI GB, Molinuevo JL, Altomare D, Carrera E, et al
    Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies.
    Alzheimers Dement. 2020 Aug 20. doi: 10.1002/alz.12132.
    PubMed     Abstract available


  99. FINSTERWALDER S, Vlegels N, Gesierich B, Araque Caballero MA, et al
    Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients.
    Alzheimers Dement. 2020 Aug 18. doi: 10.1002/alz.12150.
    PubMed     Abstract available


  100. LIN PJ, Cohen JT, Neumann PJ
    Preparing the health-care system to pay for new Alzheimer's drugs.
    Alzheimers Dement. 2020 Aug 18. doi: 10.1002/alz.12155.
    PubMed     Abstract available


  101. DENNY A, Streitz M, Stock K, Balls-Berry JE, et al
    Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018.
    Alzheimers Dement. 2020 Aug 17. doi: 10.1002/alz.12160.
    PubMed     Abstract available


  102. WU CY, Ouk M, Wong YY, Anita NZ, et al
    Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status.
    Alzheimers Dement. 2020 Aug 16. doi: 10.1002/alz.12161.
    PubMed     Abstract available


  103. MOK VCT, Pendlebury S, Wong A, Alladi S, et al
    Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future.
    Alzheimers Dement. 2020 Aug 12. doi: 10.1002/alz.12143.
    PubMed     Abstract available


  104. JIA L, Zhu M, Kong C, Pang Y, et al
    Blood neuro-exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage.
    Alzheimers Dement. 2020 Aug 10. doi: 10.1002/alz.12166.
    PubMed     Abstract available


  105. NHO K, Nudelman K, Allen M, Hodges A, et al
    Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology.
    Alzheimers Dement. 2020 Aug 5. doi: 10.1002/alz.12092.
    PubMed     Abstract available


    July 2020
  106. GUSTAFSON DR, Backman K, Scarmeas N, Stern Y, et al
    Dietary fatty acids and risk of Alzheimer's disease and related dementias: Observations from the Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP).
    Alzheimers Dement. 2020 Jul 27. doi: 10.1002/alz.12154.
    PubMed     Abstract available


  107. BOADA M, Lopez OL, Olazaran J, Nunez L, et al
    A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study.
    Alzheimers Dement. 2020 Jul 27. doi: 10.1002/alz.12137.
    PubMed     Abstract available


  108. VIDONI ED, Choi IY, Lee P, Reed G, et al
    Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.
    Alzheimers Dement. 2020 Jul 27. doi: 10.1002/alz.12156.
    PubMed     Abstract available


  109. KLING MA, Goodenowe DB, Senanayake V, MahmoudianDehkordi S, et al
    Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.
    Alzheimers Dement. 2020 Jul 27. doi: 10.1002/alz.12110.
    PubMed     Abstract available


  110. XU W, Tan L, Su BJ, Yu H, et al
    Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: The CABLE study.
    Alzheimers Dement. 2020 Jul 13. doi: 10.1002/alz.12117.
    PubMed     Abstract available


    June 2020
  111. CASELLI RJ, Knopman DS, Bu G
    An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis.
    Alzheimers Dement. 2020 Jun 26. doi: 10.1002/alz.12124.
    PubMed     Abstract available


  112. LUTZ MW, Luo S, Williamson DE, Chiba-Falek O, et al
    Shared genetic etiology underlying late-onset Alzheimer's disease and posttraumatic stress syndrome.
    Alzheimers Dement. 2020 Jun 26. doi: 10.1002/alz.12128.
    PubMed     Abstract available


  113. EREN E, Hunt JFV, Shardell M, Chawla S, et al
    Extracellular vesicle biomarkers of Alzheimer's disease associated with sub-clinical cognitive decline in late middle age.
    Alzheimers Dement. 2020 Jun 26. doi: 10.1002/alz.12130.
    PubMed     Abstract available



  114. New Thinking About Thinking, Part 3. Advice on preparing a successful manuscript for Alzheimer's & Dementia.
    Alzheimers Dement. 2020 Jun 24. doi: 10.1002/alz.12141.
    PubMed    


  115. MILA-ALOMA M, Salvado G, Gispert JD, Vilor-Tejedor N, et al
    Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.
    Alzheimers Dement. 2020 Jun 23. doi: 10.1002/alz.12131.
    PubMed     Abstract available


  116. SHERVA R, Gross A, Mukherjee S, Koesterer R, et al
    Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.
    Alzheimers Dement. 2020 Jun 23. doi: 10.1002/alz.12106.
    PubMed     Abstract available


  117. AZAR M, Chapman S, Gu Y, Leverenz JB, et al
    Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study.
    Alzheimers Dement. 2020 Jun 19. doi: 10.1002/alz.12120.
    PubMed     Abstract available


  118. SNYDER HM, Bain LJ, Brickman AM, Carrillo MC, et al
    Further understanding the connection between Alzheimer's disease and Down syndrome.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12112.
    PubMed     Abstract available


  119. SWERDLOW RH, Hui D, Chalise P, Sharma P, et al
    Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12119.
    PubMed     Abstract available


  120. COCROFT S, Welsh-Bohmer KA, Plassman BL, Chanti-Ketterl M, et al
    Racially diverse participant registries to facilitate the recruitment of African Americans into presymptomatic Alzheimer's disease studies.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12048.
    PubMed     Abstract available


  121. BERMEJO-PAREJA F, Del Ser T, Valenti M, de la Fuente M, et al
    Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12107.
    PubMed     Abstract available


  122. BI D, Wen L, Wu Z, Shen Y, et al
    GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12088.
    PubMed     Abstract available


  123. GENTREAU M, Chuy V, Feart C, Samieri C, et al
    Refined carbohydrate-rich diet is associated with long-term risk of dementia and Alzheimer's disease in apolipoprotein E epsilon4 allele carriers.
    Alzheimers Dement. 2020 Jun 7. doi: 10.1002/alz.12114.
    PubMed     Abstract available


  124. FIRTH NC, Primativo S, Brotherhood E, Young AL, et al
    Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event-based model of disease progression.
    Alzheimers Dement. 2020 Jun 2. doi: 10.1002/alz.12083.
    PubMed     Abstract available


    May 2020
  125. ORDING AG, Horvath-Puho E, Veres K, Glymour MM, et al
    Cancer and risk of Alzheimer's disease: Small association in a nationwide cohort study.
    Alzheimers Dement. 2020 May 20. doi: 10.1002/alz.12090.
    PubMed     Abstract available


  126. KNOPMAN D, Lemere CA, Lamb BT, Craft S, et al
    Scientific Advising and Reviewing: On strengthening the bond between the Alzheimer's Association and the scientific community.
    Alzheimers Dement. 2020 May 19. doi: 10.1002/alz.12059.
    PubMed     Abstract available


  127. RIOS-ROMENETS S, Lopera F, Sink KM, Hu N, et al
    Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial.
    Alzheimers Dement. 2020 May 17. doi: 10.1002/alz.12109.
    PubMed     Abstract available


  128. MECCA AP, Chen MK, O'Dell RS, Naganawa M, et al
    In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.
    Alzheimers Dement. 2020 May 13. doi: 10.1002/alz.12097.
    PubMed     Abstract available


  129. MOORE EE, Gifford KA, Khan OA, Liu D, et al
    Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease.
    Alzheimers Dement. 2020 May 6. doi: 10.1002/alz.12087.
    PubMed     Abstract available


  130. RENTZ DM, Wessels AM, Bain LJ, Weber CJ, et al
    Clinical meaningfulness addressed at Alzheimer's Association Research Roundtable.
    Alzheimers Dement. 2020;16:814.
    PubMed    


    April 2020
  131. JORGENSEN IF, Aguayo-Orozco A, Lademann M, Brunak S, et al
    Age-stratified longitudinal study of Alzheimer's and vascular dementia patients.
    Alzheimers Dement. 2020 Apr 27. doi: 10.1002/alz.12091.
    PubMed     Abstract available


  132. DE FLORES R, Wisse LEM, Das SR, Xie L, et al
    Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
    Alzheimers Dement. 2020 Apr 22. doi: 10.1002/alz.12079.
    PubMed     Abstract available


  133. MURAOKA S, DeLeo AM, Sethi MK, Yukawa-Takamatsu K, et al
    Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues.
    Alzheimers Dement. 2020 Apr 17. doi: 10.1002/alz.12089.
    PubMed     Abstract available


  134. TRARES K, Gao X, Perna L, Rujescu D, et al
    Associations of urinary 8-iso-prostaglandin F2alpha levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence: results from a prospective cohort study.
    Alzheimers Dement. 2020 Apr 12. doi: 10.1002/alz.12081.
    PubMed     Abstract available


  135. LOPES ALVES I, Collij LE, Altomare D, Frisoni GB, et al
    Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study.
    Alzheimers Dement. 2020 Apr 12. doi: 10.1002/alz.12069.
    PubMed     Abstract available


  136. DONOHUE MC, Model F, Delmar P, Volye N, et al
    Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach.
    Alzheimers Dement. 2020 Apr 8. doi: 10.1002/alz.12058.
    PubMed     Abstract available


  137. GEERTS H, Spiros A
    Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach.
    Alzheimers Dement. 2020 Apr 7. doi: 10.1002/alz.12082.
    PubMed     Abstract available


  138. CABALLERO MAA, Song Z, Rubinski A, Duering M, et al
    Age-dependent amyloid deposition is associated with white matter alterations in cognitively normal adults during the adult life span.
    Alzheimers Dement. 2020;16:651-661.
    PubMed     Abstract available


    March 2020

  139. Alzheimer's Disease Research Enterprise in the Era of COVID-19/SARS-CoV-2.
    Alzheimers Dement. 2020 Mar 22. doi: 10.1002/alz.12093.
    PubMed    



  140. 2020 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2020 Mar 10. doi: 10.1002/alz.12068.
    PubMed     Abstract available


  141. JANSSEN O, Vos SJB, Garcia-Negredo G, Tochel C, et al
    Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube.
    Alzheimers Dement. 2020;16:461-471.
    PubMed     Abstract available


  142. LOWE VJ, Lundt ES, Albertson SM, Min HK, et al
    Tau-positron emission tomography correlates with neuropathology findings.
    Alzheimers Dement. 2020;16:561-571.
    PubMed     Abstract available


  143. PAPP KV, Buckley R, Mormino E, Maruff P, et al
    Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD.
    Alzheimers Dement. 2020;16:552-560.
    PubMed     Abstract available


    February 2020
  144. XIONG C, Luo J, Coble D, Agboola F, et al
    Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia.
    Alzheimers Dement. 2020 Feb 17. doi: 10.1002/alz.12060.
    PubMed     Abstract available


  145. SCHAFFERT J, LoBue C, White CL 3rd, Wilmoth K, et al
    Risk factors for earlier dementia onset in autopsy-confirmed Alzheimer's disease, mixed Alzheimer's with Lewy bodies, and pure Lewy body disease.
    Alzheimers Dement. 2020 Feb 11. doi: 10.1002/alz.12049.
    PubMed     Abstract available


  146. FRANZMEIER N, Koutsouleris N, Benzinger T, Goate A, et al
    Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning.
    Alzheimers Dement. 2020 Feb 11. doi: 10.1002/alz.12032.
    PubMed     Abstract available



  147. Bill Gates funds $10 million grant to Alzheimer's Association to fuel research for Alzheimer's treatment.
    Alzheimers Dement. 2020;16:384.
    PubMed    


  148. ANTONELL A, Tort-Merino A, Rios J, Balasa M, et al
    Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.
    Alzheimers Dement. 2020;16:262-272.
    PubMed     Abstract available


  149. ANGULO SL, Henzi T, Neymotin SA, Suarez MD, et al
    Amyloid pathology-produced unexpected modifications of calcium homeostasis in hippocampal subicular dendrites.
    Alzheimers Dement. 2020;16:251-261.
    PubMed     Abstract available


    January 2020
  150. HERRING WJ, Ceesay P, Snyder E, Bliwise D, et al
    Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial.
    Alzheimers Dement. 2020 Jan 15. doi: 10.1002/alz.12035.
    PubMed     Abstract available


  151. JIA L, Fu Y, Shen L, Zhang H, et al
    PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer's disease.
    Alzheimers Dement. 2020;16:178-191.
    PubMed     Abstract available


  152. SNYDER PJ, Snyder HM, Bain LJ
    Retinal imaging think tank convened by the Alzheimer's Association to examine its promise in the early detection of Alzheimer's.
    Alzheimers Dement. 2020;16:244.
    PubMed    


  153. ALBER J, Goldfarb D, Thompson LI, Arthur E, et al
    Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward.
    Alzheimers Dement. 2020;16:229-243.
    PubMed     Abstract available


  154. PATHAK GA, Zhou Z, Silzer TK, Barber RC, et al
    Two-stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer's and cancer.
    Alzheimers Dement. 2020;16:162-177.
    PubMed     Abstract available


  155. ASCHENBRENNER AJ, James BD, McDade E, Wang G, et al
    Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN).
    Alzheimers Dement. 2020;16:219-228.
    PubMed     Abstract available


  156. LINARD M, Letenneur L, Garrigue I, Doize A, et al
    Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease.
    Alzheimers Dement. 2020;16:200-208.
    PubMed     Abstract available


  157. KAPLOW J, Vandijck M, Gray J, Kanekiyo M, et al
    Concordance of Lumipulse cerebrospinal fluid t-tau/Abeta42 ratio with amyloid PET status.
    Alzheimers Dement. 2020;16:144-152.
    PubMed     Abstract available


    December 2019
  158. ELAHI FM, Casaletto KB, La Joie R, Walters SM, et al
    Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease.
    Alzheimers Dement. 2019 Dec 23. pii: S1552-5260(19)35373.
    PubMed     Abstract available


  159. SABBAGH M, Sadowsky C, Tousi B, Agronin ME, et al
    Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease.
    Alzheimers Dement. 2019 Dec 23. pii: S1552-5260(19)35367.
    PubMed     Abstract available


    November 2019
  160. JANSSEN O, Vos SJB, Garcia-Negredo G, Tochel C, et al
    Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube.
    Alzheimers Dement. 2019 Nov 27. pii: S1552-5260(19)35487.
    PubMed     Abstract available


  161. ANDREWS SJ, Goate A, Anstey KJ
    Association between alcohol consumption and Alzheimer's disease: A Mendelian randomization study.
    Alzheimers Dement. 2019 Nov 27. pii: S1552-5260(19)35486.
    PubMed     Abstract available


  162. GONZALEZ HM, Tarraf W, Fornage M, Gonzalez KA, et al
    A research framework for cognitive aging and Alzheimer's disease among diverse US Latinos: Design and implementation of the Hispanic Community Health Study/Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).
    Alzheimers Dement. 2019 Nov 20. pii: S1552-5260(19)35362.
    PubMed     Abstract available


  163. TOLAR M, Abushakra S, Sabbagh M
    The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis.
    Alzheimers Dement. 2019 Nov 4. pii: S1552-5260(19)35450.
    PubMed     Abstract available



  164. Corrigendum to "AMYPAD Diagnostic and Patient Management Study: Rationale and design" [Alzheimer's & Dementia 2019;15:388-99].
    Alzheimers Dement. 2019;15:1505.
    PubMed    


    October 2019
  165. ISAACSON RS, Hristov H, Saif N, Hackett K, et al
    Individualized clinical management of patients at risk for Alzheimer's dementia.
    Alzheimers Dement. 2019 Oct 31. pii: S1552-5260(19)35368.
    PubMed     Abstract available


  166. PULINA MV, Hopkins M, Haroutunian V, Greengard P, et al
    C99 selectively accumulates in vulnerable neurons in Alzheimer's disease.
    Alzheimers Dement. 2019 Oct 30. pii: S1552-5260(19)35370.
    PubMed     Abstract available


  167. OSSENKOPPELE R, Lyoo CH, Sudre CH, van Westen D, et al
    Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
    Alzheimers Dement. 2019 Oct 28. pii: S1552-5260(19)35375.
    PubMed     Abstract available


  168. BROSSERON F, Kolbe CC, Santarelli F, Carvalho S, et al
    Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study.
    Alzheimers Dement. 2019 Oct 17. pii: S1552-5260(19)35352.
    PubMed     Abstract available


  169. STOCKER H, Nabers A, Perna L, Mollers T, et al
    Prediction of Alzheimer's disease diagnosis within 14 years through Abeta misfolding in blood plasma compared to APOE4 status, and other risk factors.
    Alzheimers Dement. 2019 Oct 11. pii: S1552-5260(19)35349.
    PubMed     Abstract available


  170. GLEASON CE, Norton D, Zuelsdorff M, Benton SF, et al
    Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease Center.
    Alzheimers Dement. 2019 Oct 6. pii: S1552-5260(19)35138.
    PubMed     Abstract available


  171. OGINO E, Manly JJ, Schupf N, Mayeux R, et al
    Current and past leisure time physical activity in relation to risk of Alzheimer's disease in older adults.
    Alzheimers Dement. 2019 Oct 3. pii: S1552-5260(19)35136.
    PubMed     Abstract available


  172. EHRHARDT S, Porsteinsson AP, Munro CA, Rosenberg PB, et al
    Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.
    Alzheimers Dement. 2019 Oct 3. pii: S1552-5260(19)35112.
    PubMed     Abstract available


    September 2019
  173. MCRAE-MCKEE K, Udeh-Momoh CT, Price G, Bajaj S, et al
    Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?
    Alzheimers Dement. 2019 Sep 26. pii: S1552-5260(19)35133.
    PubMed     Abstract available


  174. BLUE EE, Horimoto ARVR, Mukherjee S, Wijsman EM, et al
    Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics.
    Alzheimers Dement. 2019 Sep 25. pii: S1552-5260(19)35348.
    PubMed     Abstract available


  175. SCHAEFER KR, Noonan C, Mosley M, Smith J, et al
    Differences in service utilization at an urban tribal health organization before and after Alzheimer's disease or related dementia diagnosis: A cohort study.
    Alzheimers Dement. 2019 Sep 20. pii: S1552-5260(19)35111.
    PubMed     Abstract available


  176. HUQ AJ, Fransquet P, Laws SM, Ryan J, et al
    Genetic resilience to Alzheimer's disease in APOE epsilon4 homozygotes: A systematic review.
    Alzheimers Dement. 2019 Sep 7. pii: S1552-5260(19)30152.
    PubMed     Abstract available


  177. XIONG C, Luo J, Agboola F, Li Y, et al
    A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials.
    Alzheimers Dement. 2019 Sep 7. pii: S1552-5260(19)35122.
    PubMed     Abstract available


  178. THOMAS KR, Edmonds EC, Eppig JS, Wong CG, et al
    MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2019 Sep 5. pii: S1552-5260(19)35115.
    PubMed     Abstract available


  179. TAKOUSIS P, Sadlon A, Schulz J, Wohlers I, et al
    Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid.
    Alzheimers Dement. 2019 Sep 5. pii: S1552-5260(19)35119.
    PubMed     Abstract available


  180. FINCH CE, Kulminski AM
    The Alzheimer's Disease Exposome.
    Alzheimers Dement. 2019 Sep 3. pii: S1552-5260(19)34079.
    PubMed     Abstract available


    August 2019
  181. MC ARDLE R, Galna B, Donaghy P, Thomas A, et al
    Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?
    Alzheimers Dement. 2019 Aug 30. pii: S1552-5260(19)35120.
    PubMed     Abstract available


  182. STARTIN CM, Hamburg S, Hithersay R, Al-Janabi T, et al
    Reply to "Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management".
    Alzheimers Dement. 2019 Aug 23. pii: S1552-5260(19)30138.
    PubMed    


  183. LI B, He Y, Ma J, Huang P, et al
    Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Alzheimers Dement. 2019 Aug 13. pii: S1552-5260(19)35123.
    PubMed     Abstract available


  184. MORENO-GRAU S, de Rojas I, Hernandez I, Quintela I, et al
    Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.
    Alzheimers Dement. 2019 Aug 13. pii: S1552-5260(19)35117.
    PubMed     Abstract available


  185. OTTOY J, Verhaeghe J, Niemantsverdriet E, De Roeck E, et al
    (18)F-FDG PET, the early phases and the delivery rate of (18)F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against (15)O-H2O PET.
    Alzheimers Dement. 2019 Aug 9. pii: S1552-5260(19)30151.
    PubMed     Abstract available


  186. JELLINGER KA
    Traumatic brain injury and Alzheimer's disease neuropathology.
    Alzheimers Dement. 2019 Aug 8. pii: S1552-5260(19)34082.
    PubMed    


  187. GREEN C, Handels R, Gustavsson A, Wimo A, et al
    Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework.
    Alzheimers Dement. 2019 Aug 8. pii: S1552-5260(19)30139.
    PubMed     Abstract available


  188. OH J, Eser RA, Ehrenberg AJ, Morales D, et al
    Profound degeneration of wake-promoting neurons in Alzheimer's disease.
    Alzheimers Dement. 2019 Aug 8. pii: S1552-5260(19)34081.
    PubMed     Abstract available


  189. SAKAE N, Josephs KA, Litvan I, Murray ME, et al
    Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome.
    Alzheimers Dement. 2019 Aug 6. pii: S1552-5260(19)30115.
    PubMed     Abstract available


  190. YU JT, Li JQ, Suckling J, Feng L, et al
    Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study.
    Alzheimers Dement. 2019 Aug 6. pii: S1552-5260(19)30147.
    PubMed     Abstract available


  191. BOS I, Vos SJB, Schindler SE, Hassenstab J, et al
    Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.
    Alzheimers Dement. 2019 Aug 1. pii: S1552-5260(19)30122.
    PubMed     Abstract available


  192. MAHLA RS
    Down syndrome cognitive marker's significance in Alzheimer's disease and dementia management.
    Alzheimers Dement. 2019;15:1117-1118.
    PubMed    


  193. ELDADAH BA, Fazio EM, McLinden KA
    Lucidity in dementia: A perspective from the NIA.
    Alzheimers Dement. 2019;15:1104-1106.
    PubMed     Abstract available


    July 2019
  194. FILSHTEIN TJ, Brenowitz WD, Mayeda ER, Hohman TJ, et al
    Reserve and Alzheimer's disease genetic risk: Effects on hospitalization and mortality.
    Alzheimers Dement. 2019;15:907-916.
    PubMed     Abstract available


    June 2019
  195. LUTZ MW, Sprague D, Chiba-Falek O
    Bioinformatics strategy to advance the interpretation of Alzheimer's disease GWAS discoveries: The roads from association to causation.
    Alzheimers Dement. 2019 Jun 28. pii: S1552-5260(19)30121.
    PubMed     Abstract available


  196. LI H, Habes M, Wolk DA, Fan Y, et al
    A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data.
    Alzheimers Dement. 2019 Jun 11. pii: S1552-5260(19)30086.
    PubMed     Abstract available


  197. STRANDBERG TE, Tienari PJ
    Contributions of vascular and Alzheimer's disease pathology to dementia.
    Alzheimers Dement. 2019 Jun 11. pii: S1552-5260(19)30108.
    PubMed    


  198. MIRON J, Picard C, Lafaille-Magnan ME, Savard M, et al
    Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation.
    Alzheimers Dement. 2019 Jun 4. pii: S1552-5260(19)30087.
    PubMed     Abstract available


  199. VERMUNT L, Sikkes SAM, van den Hout A, Handels R, et al
    Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
    Alzheimers Dement. 2019 Jun 1. pii: S1552-5260(19)30084.
    PubMed     Abstract available


    May 2019
  200. CHIESA PA, Cavedo E, Vergallo A, Lista S, et al
    Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease.
    Alzheimers Dement. 2019 May 18. pii: S1552-5260(19)30077.
    PubMed     Abstract available


  201. VERGALLO A, Megret L, Lista S, Cavedo E, et al
    Plasma amyloid beta 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.
    Alzheimers Dement. 2019 May 18. pii: S1552-5260(19)30082.
    PubMed     Abstract available


  202. RODRIGUEZ-GOMEZ O, Rodrigo A, Iradier F, Santos-Santos MA, et al
    The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community.
    Alzheimers Dement. 2019 May 6. pii: S1552-5260(19)30072.
    PubMed     Abstract available



  203. Erratum to "Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice" [Alzheimer's & Dementia 2016;12:1273-87.].
    Alzheimers Dement. 2019 May 4. pii: S1552-5260(19)30117.
    PubMed    


  204. SCHEEPERS LEJM, Jacobsson LTH, Kern S, Johansson L, et al
    Urate and risk of Alzheimer's disease and vascular dementia: A population-based study.
    Alzheimers Dement. 2019 May 2. pii: S1552-5260(19)30046.
    PubMed     Abstract available


    April 2019
  205. MORGAN AR, Touchard S, Leckey C, O'Hagan C, et al
    Inflammatory biomarkers in Alzheimer's disease plasma.
    Alzheimers Dement. 2019 Apr 29. pii: S1552-5260(19)30078.
    PubMed     Abstract available


  206. KIM M, Snowden S, Suvitaival T, Ali A, et al
    Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
    Alzheimers Dement. 2019 Apr 28. pii: S1552-5260(19)30074.
    PubMed     Abstract available


  207. WOO BKP, Chung S, Woo G, Chung JOP, et al
    Mitigating stigma of Alzheimer's disease dementia among Chinese Americans.
    Alzheimers Dement. 2019 Apr 25. pii: S1552-5260(19)30079.
    PubMed    


  208. GOEDERT M
    Aaron Klug and the study of Alzheimer's disease.
    Alzheimers Dement. 2019 Apr 19. pii: S1552-5260(19)30054.
    PubMed    


  209. LLEO A, Alcolea D, Martinez-Lage P, Scheltens P, et al
    Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
    Alzheimers Dement. 2019 Apr 6. pii: S1552-5260(19)30047.
    PubMed     Abstract available


    March 2019
  210. BIHLMEYER NA, Merrill E, Lambert Y, Srivastava GP, et al
    Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 29. pii: S1552-5260(19)30032.
    PubMed     Abstract available



  211. Erratum to "Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome" [Alzheimer's & Dementia 2019;15:76-92.].
    Alzheimers Dement. 2019 Mar 21. pii: S1552-5260(19)30055.
    PubMed    


  212. KOUNTOURAS J, Doulberis M, Polyzos SA, Katsinelos T, et al
    Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia.
    Alzheimers Dement. 2019 Mar 11. pii: S1552-5260(19)30029.
    PubMed    


  213. WHITWELL JL, Martin P, Graff-Radford J, Machulda MM, et al
    The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30010.
    PubMed     Abstract available


  214. BOS I, Vos S, Verhey F, Scheltens P, et al
    Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
    Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30018.
    PubMed     Abstract available


  215. JELLINGER KA
    Primary age-related tauopathy (PART) and Alzheimer's disease (AD).
    Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30019.
    PubMed    


  216. SUGARMAN MA, McKee AC, Stein TD, Tripodis Y, et al
    Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia.
    Alzheimers Dement. 2019 Mar 6. pii: S1552-5260(19)30009.
    PubMed     Abstract available


  217. SCHINDLER SE, Li Y, Todd KW, Herries EM, et al
    Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 4. pii: S1552-5260(19)30013.
    PubMed     Abstract available


    February 2019
  218. GUTIERREZ J, Guzman V, Khasiyev F, Manly J, et al
    Brain arterial dilatation and the risk of Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 28. pii: S1552-5260(19)30012.
    PubMed     Abstract available


  219. JELLINGER KA
    Parkinsonism in MCI or mild Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 28. pii: S1552-5260(19)30002.
    PubMed    


  220. ZHANG F, Zhong R, Li S, Fu Z, et al
    Alteration in sleep architecture and electroencephalogram as an early sign of Alzheimer's disease preceding the disease pathology and cognitive decline.
    Alzheimers Dement. 2019 Feb 25. pii: S1552-5260(18)33621.
    PubMed     Abstract available


  221. WANG G, Coble D, McDade EM, Hassenstab J, et al
    Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset.
    Alzheimers Dement. 2019 Feb 14. pii: S1552-5260(18)33625.
    PubMed     Abstract available


  222. SANTOS OA, Pedraza O, Lucas JA, Duara R, et al
    Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort.
    Alzheimers Dement. 2019 Feb 12. pii: S1552-5260(18)33630.
    PubMed     Abstract available


  223. ROGALSKI EJ, Sridhar J, Martersteck A, Rader B, et al
    Clinical and cortical decline in the aphasic variant of Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 11. pii: S1552-5260(18)33620.
    PubMed     Abstract available


  224. LANGBAUM JB, Karlawish J, Roberts JS, Wood EM, et al
    GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
    Alzheimers Dement. 2019 Feb 6. pii: S1552-5260(18)33624.
    PubMed     Abstract available



  225. Erratum to "Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults" [Alzheimer's & Dementia 2018;14:1640-50.].
    Alzheimers Dement. 2019;15:319.
    PubMed    



  226. Erratum to "Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies" [Alzheimer's & Dementia 2018;14:707-22.].
    Alzheimers Dement. 2019;15:319.
    PubMed    


    January 2019
  227. WOSTYN P, Van Dam D, De Deyn PP
    Alzheimer's disease and glaucoma: Look-alike neurodegenerative diseases.
    Alzheimers Dement. 2019 Jan 31. pii: S1552-5260(18)33629.
    PubMed    


  228. MATTSSON N, Insel PS, Donohue M, Jogi J, et al
    Predicting diagnosis and cognition with (18)F-AV-1451 tau PET and structural MRI in Alzheimer's disease.
    Alzheimers Dement. 2019 Jan 9. pii: S1552-5260(18)33605.
    PubMed     Abstract available


  229. THOMAS KR, Eppig JS, Weigand AJ, Edmonds EC, et al
    Artificially low mild cognitive impairment to normal reversion rate in Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2019 Jan 2. pii: S1552-5260(18)33603.
    PubMed     Abstract available


  230. MCCLEERY J, Flicker L, Richard E, Quinn TJ, et al
    The National Institute on Aging and Alzheimer's Association research framework: A commentary from the Cochrane Dementia and Cognitive Improvement Group.
    Alzheimers Dement. 2019;15:179-181.
    PubMed    


  231. SWEENEY MD, Montagne A, Sagare AP, Nation DA, et al
    Vascular dysfunction-The disregarded partner of Alzheimer's disease.
    Alzheimers Dement. 2019;15:158-167.
    PubMed     Abstract available


  232. JAGUST W, Jack CR Jr, Bennett DA, Blennow K, et al
    "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia".
    Alzheimers Dement. 2019;15:153-157.
    PubMed    


  233. LOUIE R
    The 2018 NIA-AA research framework: Recommendation and comments.
    Alzheimers Dement. 2019;15:182-183.
    PubMed    


  234. ALTIMUS CM, Keller K, Brannelly P, Ross E, et al
    Analysis of tauopathy research funding between 2006 and 2016 reveals critical gaps in research priorities.
    Alzheimers Dement. 2019;15:42-54.
    PubMed     Abstract available


    December 2018
  235. SLOT RER, Sikkes SAM, Berkhof J, Brodaty H, et al
    Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.
    Alzheimers Dement. 2018 Dec 13. pii: S1552-5260(18)33563.
    PubMed     Abstract available


  236. BABULAL GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, et al
    Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
    Alzheimers Dement. 2018 Dec 13. pii: S1552-5260(18)33556.
    PubMed     Abstract available


    November 2018
  237. ZHANG X, Zhu C, Beecham G, Vardarajan BN, et al
    A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 29. pii: S1552-5260(18)33579.
    PubMed     Abstract available


  238. XIONG F, Ge W, Ma C
    Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 28. pii: S1552-5260(18)33580.
    PubMed     Abstract available


  239. BELL WR, An Y, Kageyama Y, English C, et al
    Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy and Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 19. pii: S1552-5260(18)33483.
    PubMed     Abstract available


  240. LATIMER CS, Shively CA, Keene CD, Jorgensen MJ, et al
    A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis.
    Alzheimers Dement. 2018 Nov 19. pii: S1552-5260(18)33246.
    PubMed     Abstract available


  241. STARTIN CM, Hamburg S, Hithersay R, Al-Janabi T, et al
    Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome.
    Alzheimers Dement. 2018 Nov 15. pii: S1552-5260(18)33518.
    PubMed     Abstract available


  242. CHEN Z, Mengel D, Keshavan A, Rissman RA, et al
    Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 9. pii: S1552-5260(18)33561.
    PubMed     Abstract available


  243. ISAACSON RS, Ganzer CA, Hristov H, Hackett K, et al
    The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.
    Alzheimers Dement. 2018 Nov 5. pii: S1552-5260(18)33513.
    PubMed     Abstract available


    October 2018
  244. PALMQVIST S, Insel PS, Zetterberg H, Blennow K, et al
    Accurate risk estimation of beta-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms.
    Alzheimers Dement. 2018 Oct 23. pii: S1552-5260(18)33524.
    PubMed     Abstract available


  245. JOIE R, Ayakta N, Seeley WW, Borys E, et al
    Multisite study of the relationships between antemortem [(11)C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Oct 19. pii: S1552-5260(18)33523.
    PubMed     Abstract available


  246. NHO K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, et al
    Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
    Alzheimers Dement. 2018 Oct 15. pii: S1552-5260(18)33521.
    PubMed     Abstract available


  247. HU X, Teunissen C, Spottke A, Heneka MT, et al
    Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease-Data from three memory clinic studies.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33527.
    PubMed     Abstract available


  248. VEITCH DP, Weiner MW, Aisen PS, Beckett LA, et al
    Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33514.
    PubMed     Abstract available


  249. HUANG F, Wang M, Liu R, Wang JZ, et al
    CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33522.
    PubMed     Abstract available


  250. SANDELIUS A, Portelius E, Kallen A, Zetterberg H, et al
    Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33515.
    PubMed     Abstract available


  251. MOIR RD, Lathe R, Tanzi RE
    The antimicrobial protection hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 9. pii: S1552-5260(18)33228.
    PubMed     Abstract available


  252. MAHMOUDIANDEHKORDI S, Arnold M, Nho K, Ahmad S, et al
    Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
    Alzheimers Dement. 2018 Oct 8. pii: S1552-5260(18)33486.
    PubMed     Abstract available


  253. SHAW LM, Arias J, Blennow K, Galasko D, et al
    Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 3. pii: S1552-5260(18)33492.
    PubMed     Abstract available


  254. KODIS EJ, Choi S, Swanson E, Ferreira G, et al
    N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-beta oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Alzheimers Dement. 2018;14:1302-1312.
    PubMed     Abstract available


    September 2018
  255. MULLER S, Preische O, Sohrabi HR, Graber S, et al
    Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2018 Sep 21. pii: S1552-5260(18)33248.
    PubMed     Abstract available


  256. RASMUSSEN KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF, et al
    An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer's disease-A cohort study of 95,442 individuals.
    Alzheimers Dement. 2018 Sep 19. pii: S1552-5260(18)33496.
    PubMed     Abstract available


  257. LIN YF, Smith AV, Aspelund T, Betensky RA, et al
    Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms.
    Alzheimers Dement. 2018 Sep 18. pii: S1552-5260(18)33493.
    PubMed     Abstract available


  258. MATTHEWS KA, Xu W, Gaglioti AH, Holt JB, et al
    Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >/=65 years.
    Alzheimers Dement. 2018 Sep 17. pii: S1552-5260(18)33252.
    PubMed     Abstract available


  259. SASAKI S
    High prevalence of parkinsonism in patients with MCI or mild Alzheimer's disease.
    Alzheimers Dement. 2018 Sep 14. pii: S1552-5260(18)33243.
    PubMed     Abstract available


  260. RAJAN KB, Weuve J, Barnes LL, Wilson RS, et al
    Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study.
    Alzheimers Dement. 2018 Sep 6. pii: S1552-5260(18)33484.
    PubMed     Abstract available


  261. CAVEDO E, Chiesa PA, Houot M, Ferretti MT, et al
    Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.
    Alzheimers Dement. 2018;14:1204-1215.
    PubMed     Abstract available


  262. BEYDOUN MA, Beydoun HA, Elbejjani M, Dore GA, et al
    Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys.
    Alzheimers Dement. 2018;14:1148-1158.
    PubMed     Abstract available


  263. MIELKE MM, Ferretti MT, Iulita MF, Hayden K, et al
    Sex and gender in Alzheimer's disease - Does it matter?
    Alzheimers Dement. 2018;14:1101-1103.
    PubMed    


    August 2018
  264. NICOLAS G, Acuna-Hidalgo R, Keogh MJ, Quenez O, et al
    Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 13. pii: S1552-5260(18)33245.
    PubMed     Abstract available


  265. TANG Y, Lutz MW, Xing Y
    A systems-based model of Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 10. pii: S1552-5260(18)33247.
    PubMed     Abstract available


  266. LEE CS, Larson EB, Gibbons LE, Lee AY, et al
    Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 2. pii: S1552-5260(18)33034.
    PubMed     Abstract available


    July 2018
  267. VERGALLO A, Bun RS, Toschi N, Baldacci F, et al
    Association of cerebrospinal fluid alpha-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers.
    Alzheimers Dement. 2018 Jul 25. pii: S1552-5260(18)33241.
    PubMed     Abstract available


    June 2018
  268. RUTHIRAKUHAN M, Lanctot KL, Di Scipio M, Ahmed M, et al
    Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30157.
    PubMed     Abstract available


  269. HANSSON O, Mikulskis A, Fagan AM, Teunissen C, et al
    The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30162.
    PubMed     Abstract available


  270. YOO HS, Jeon S, Chung SJ, Evans AC, et al
    Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30164.
    PubMed     Abstract available


  271. CUMMINGS J
    The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30160.
    PubMed     Abstract available


    May 2018
  272. NEBEL RA, Aggarwal NT, Barnes LL, Gallagher A, et al
    Understanding the impact of sex and gender in Alzheimer's disease: A call to action.
    Alzheimers Dement. 2018 May 31. pii: S1552-5260(18)30130.
    PubMed     Abstract available


  273. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.
    Alzheimers Dement. 2018 May 26. pii: S1552-5260(18)30155.
    PubMed    


  274. BUCKLEY RF, Mormino EC, Amariglio RE, Properzi MJ, et al
    Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
    Alzheimers Dement. 2018 May 24. pii: S1552-5260(18)30132.
    PubMed     Abstract available


  275. TEIPEL SJ, Cavedo E, Lista S, Habert MO, et al
    Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30126.
    PubMed     Abstract available


  276. JOHANSSON JU, Brubaker WD, Javitz H, Bergen AW, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30125.
    PubMed     Abstract available


  277. SAEED U, Mirza SS, MacIntosh BJ, Herrmann N, et al
    APOE-epsilon4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
    Alzheimers Dement. 2018 May 18. pii: S1552-5260(18)30127.
    PubMed     Abstract available


  278. IWATSUBO T, Iwata A, Suzuki K, Ihara R, et al
    Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
    Alzheimers Dement. 2018 May 8. pii: S1552-5260(18)30102.
    PubMed     Abstract available


  279. BROOKMEYER R, Abdalla N
    Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
    Alzheimers Dement. 2018 May 7. pii: S1552-5260(18)30098.
    PubMed     Abstract available


  280. LI P, Yu L, Lim ASP, Buchman AS, et al
    Fractal regulation and incident Alzheimer's disease in elderly individuals.
    Alzheimers Dement. 2018 May 4. pii: S1552-5260(18)30108.
    PubMed     Abstract available


    April 2018
  281. MIELKE MM, Hagen CE, Xu J, Chai X, et al
    Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.
    Alzheimers Dement. 2018 Apr 4. pii: S1552-5260(18)30067.
    PubMed     Abstract available


  282. SILVERBERG N, Elliott C, Ryan L, Masliah E, et al
    NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:576-578.
    PubMed    


  283. KNOPMAN DS, Haeberlein SB, Carrillo MC, Hendrix JA, et al
    The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
    Alzheimers Dement. 2018;14:563-575.
    PubMed     Abstract available


  284. JACK CR JR., Bennett DA, Blennow K, Carrillo MC, et al
    NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:535-562.
    PubMed     Abstract available


  285. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.
    Alzheimers Dement. 2018;14:532-534.
    PubMed    


    March 2018
  286. WHITWELL JL, Graff-Radford J, Tosakulwong N, Weigand SD, et al
    Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30074.
    PubMed     Abstract available


  287. DARWEESH SKL, Wolters FJ, Ikram MA, de Wolf F, et al
    Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30068.
    PubMed     Abstract available


  288. VERMUNT L, Veal CD, Meulen LT, Chrysostomou C, et al
    European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30064.
    PubMed     Abstract available


  289. SHI M, Tang L, Toledo JB, Ginghina C, et al
    Cerebrospinal fluid alpha-synuclein contributes to the differential diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30069.
    PubMed     Abstract available


  290. CACCIAGLIA R, Molinuevo JL, Falcon C, Brugulat-Serrat A, et al
    Effects of APOE-epsilon4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30044.
    PubMed     Abstract available


  291. MATTSSON N, Groot C, Jansen WJ, Landau S, et al
    Prevalence of the apolipoprotein E epsilon4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30063.
    PubMed     Abstract available


  292. SUTPHEN CL, McCue L, Herries EM, Xiong C, et al
    Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30031.
    PubMed     Abstract available


  293. GOLDMAN DP, Fillit H, Neumann P
    Accelerating Alzheimer's disease drug innovations from the research pipeline to patients.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30050.
    PubMed     Abstract available


  294. STITES SD, Rubright JD, Karlawish J
    What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public.
    Alzheimers Dement. 2018 Mar 17. pii: S1552-5260(18)30025.
    PubMed     Abstract available


  295. SMITH RG, Hannon E, De Jager PL, Chibnik L, et al
    Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Mar 14. pii: S1552-5260(18)30049.
    PubMed     Abstract available


  296. CONNORS MH, Seeher KM, Crawford J, Ames D, et al
    The stability of neuropsychiatric subsyndromes in Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 13. pii: S1552-5260(18)30048.
    PubMed     Abstract available


  297. CHIBA-FALEK O, Gottschalk WK, Lutz MW
    The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Alzheimers Dement. 2018 Mar 7. pii: S1552-5260(18)30043.
    PubMed     Abstract available


    February 2018
  298. TYNKKYNEN J, Chouraki V, van der Lee SJ, Hernesniemi J, et al
    Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.
    Alzheimers Dement. 2018 Feb 28. pii: S1552-5260(18)30020.
    PubMed     Abstract available


  299. HANSSON O, Seibyl J, Stomrud E, Zetterberg H, et al
    CSF biomarkers of Alzheimer's disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
    Alzheimers Dement. 2018 Feb 27. pii: S1552-5260(18)30029.
    PubMed     Abstract available


  300. AHMAD S, Bannister C, van der Lee SJ, Vojinovic D, et al
    Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study.
    Alzheimers Dement. 2018 Feb 26. pii: S1552-5260(18)30024.
    PubMed     Abstract available


  301. COHEN AD, McDade E, Christian B, Price J, et al
    Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.
    Alzheimers Dement. 2018 Feb 22. pii: S1552-5260(18)30019.
    PubMed     Abstract available


  302. HANON O, Vidal JS, Lehmann S, Bombois S, et al
    Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Alzheimers Dement. 2018 Feb 16. pii: S1552-5260(18)30021.
    PubMed     Abstract available


  303. KNOPMAN DS, Siemers ER, Bain LJ, Hendrix JA, et al
    National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease.
    Alzheimers Dement. 2018;14:261-262.
    PubMed    


    January 2018
  304. MIRON J, Picard C, Nilsson N, Frappier J, et al
    CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.
    Alzheimers Dement. 2018 Jan 19. pii: S1552-5260(17)33875.
    PubMed     Abstract available


  305. DI GUARDO G
    Alzheimer's disease, cellular prion protein, and dolphins.
    Alzheimers Dement. 2018 Jan 15. pii: S1552-5260(17)33873.
    PubMed    


  306. JIA J, Wei C, Chen S, Li F, et al
    The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
    Alzheimers Dement. 2018 Jan 11. pii: S1552-5260(17)33877.
    PubMed     Abstract available


  307. HAMPEL H, Toschi N, Baldacci F, Zetterberg H, et al
    Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Abeta1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33872.
    PubMed     Abstract available


  308. TSE KH, Cheng A, Ma F, Herrup K, et al
    DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's and dementia.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33853.
    PubMed     Abstract available


  309. ACOSTA D, Powell F, Zhao Y, Raj A, et al
    Regional vulnerability in Alzheimer's: The role of cell-autonomous and transneuronal processes.
    Alzheimers Dement. 2018 Jan 4. pii: S1552-5260(17)33857.
    PubMed     Abstract available


  310. LI K, O'Brien R, Lutz M, Luo S, et al
    A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data.
    Alzheimers Dement. 2018 Jan 3. pii: S1552-5260(17)33840.
    PubMed     Abstract available


    December 2017
  311. HALL H, Iulita MF, Gubert P, Aguilar LF, et al
    AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 29. pii: S1552-5260(17)33851.
    PubMed     Abstract available


  312. CHUNG J, Wang X, Maruyama T, Ma Y, et al
    Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages.
    Alzheimers Dement. 2017 Dec 20. pii: S1552-5260(17)33842.
    PubMed     Abstract available


  313. LEUZY A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, et al
    Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 18. pii: S1552-5260(17)33844.
    PubMed     Abstract available


  314. BECKER RE, Kapogiannis D, Greig NH
    Does traumatic brain injury hold the key to the Alzheimer's puzzle?
    Alzheimers Dement. 2017 Dec 12. pii: S1552-5260(17)33843.
    PubMed     Abstract available


  315. PASPALAS CD, Carlyle BC, Leslie S, Preuss TM, et al
    The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology.
    Alzheimers Dement. 2017 Dec 11. pii: S1552-5260(17)33841.
    PubMed     Abstract available


    November 2017
  316. BROOKMEYER R, Abdalla N, Kawas CH, Corrada MM, et al
    Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.
    Alzheimers Dement. 2017 Nov 29. pii: S1552-5260(17)33813.
    PubMed     Abstract available


  317. STEFANIAK JD, Su L, Mak E, Bahaei NS, et al
    Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Nov 18. pii: S1552-5260(17)33809.
    PubMed     Abstract available


  318. VIDONI ED, Bothwell RJ, Burns JM, Dwyer JR, et al
    Novel recruitment models will drive Alzheimer's trial success.
    Alzheimers Dement. 2017 Nov 17. pii: S1552-5260(17)33793.
    PubMed    


    October 2017
  319. MONTAL V, Vilaplana E, Alcolea D, Pegueroles J, et al
    Cortical microstructural changes along the Alzheimer's disease continuum.
    Alzheimers Dement. 2017 Oct 31. pii: S1552-5260(17)33767.
    PubMed     Abstract available


  320. ALLEN M, Wang X, Burgess JD, Watzlawik J, et al
    Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.
    Alzheimers Dement. 2017 Oct 26. pii: S1552-5260(17)33766.
    PubMed     Abstract available


  321. CRANE PK, Foroud T, Montine TJ, Larson EB, et al
    Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33764.
    PubMed     Abstract available


  322. AN Y, Varma VR, Varma S, Casanova R, et al
    Evidence for brain glucose dysregulation in Alzheimer's disease.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33765.
    PubMed     Abstract available


  323. HAMPEL H, Mesulam MM, Cuello AC, Khachaturian AS, et al
    Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research.
    Alzheimers Dement. 2017 Oct 10. pii: S1552-5260(17)33719.
    PubMed     Abstract available


    September 2017
  324. GUNN-MOORE D, Kaidanovich-Beilin O, Gallego Iradi MC, Gunn-Moore F, et al
    Alzheimer's disease in humans and other animals-A consequence of postreproductive life span and longevity rather than aging.
    Alzheimers Dement. 2017 Sep 30. pii: S1552-5260(17)33717.
    PubMed     Abstract available


  325. CRUCHAGA C, Del-Aguila JL, Saef B, Black K, et al
    Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.
    Alzheimers Dement. 2017 Sep 21. pii: S1552-5260(17)33708.
    PubMed     Abstract available


  326. XU M, Zhang DF, Luo R, Wu Y, et al
    A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 15. pii: S1552-5260(17)33707.
    PubMed     Abstract available


  327. GEERTS H, Hofmann-Apitius M, Anastasio TJ
    Knowledge-driven computational modeling in Alzheimer's research: Current state and future trends.
    Alzheimers Dement. 2017 Sep 14. pii: S1552-5260(17)33690.
    PubMed     Abstract available


  328. LIN PJ, Zhong Y, Fillit HM, Cohen JT, et al
    Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 5. pii: S1552-5260(17)33687.
    PubMed     Abstract available


    August 2017
  329. KNOPMAN D, Alford E, Tate K, Long M, et al
    Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.
    Alzheimers Dement. 2017;13:940-946.
    PubMed     Abstract available


  330. WOLF D, Bocchetta M, Preboske GM, Boccardi M, et al
    Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry.
    Alzheimers Dement. 2017;13:893-902.
    PubMed     Abstract available


  331. GRILL JD, Cox CG, Kremen S, Mendez MF, et al
    Patient and caregiver reactions to clinical amyloid imaging.
    Alzheimers Dement. 2017;13:924-932.
    PubMed     Abstract available


    July 2017
  332. CRANE A, Brubaker WD, Johansson JU, Trigunaite A, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: 2. Relationship to Abeta immunotherapy.
    Alzheimers Dement. 2017 Jul 26. pii: S1552-5260(17)32898.
    PubMed     Abstract available


  333. LUTSEY PL, Misialek JR, Mosley TH, Gottesman RF, et al
    Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32522.
    PubMed     Abstract available


  334. KINNUNEN KM, Cash DM, Poole T, Frost C, et al
    Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32521.
    PubMed     Abstract available


  335. FRAIN L, Swanson D, Cho K, Gagnon D, et al
    Association of cancer and Alzheimer's disease risk in a national cohort of veterans.
    Alzheimers Dement. 2017 Jul 12. pii: S1552-5260(17)30218.
    PubMed     Abstract available


  336. BURGGREN AC, Mahmood Z, Harrison TM, Siddarth P, et al
    Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE epsilon4 variant.
    Alzheimers Dement. 2017;13:739-748.
    PubMed     Abstract available


    June 2017
  337. CRANE PK, Trittschuh E, Mukherjee S, Saykin AJ, et al
    Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.
    Alzheimers Dement. 2017 Jun 14. pii: S1552-5260(17)30216.
    PubMed     Abstract available


  338. DRACHMAN DA, Smith TW, Alkamachi B, Kane K, et al
    Microvascular changes in Down syndrome with Alzheimer-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Alzheimers Dement. 2017 Jun 13. pii: S1552-5260(17)30219.
    PubMed     Abstract available


  339. CHOURAKI V, Preis SR, Yang Q, Beiser A, et al
    Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.
    Alzheimers Dement. 2017 Jun 8. pii: S1552-5260(17)30200.
    PubMed     Abstract available


  340. TOLPPANEN AM, Taipale H, Hartikainen S
    Head or brain injuries and Alzheimer's disease: A nested case-control register study.
    Alzheimers Dement. 2017 Jun 6. pii: S1552-5260(17)30201.
    PubMed     Abstract available


  341. PASCOAL TA, Mathotaarachchi S, Shin M, Benedet AL, et al
    Synergistic interaction between amyloid and tau predicts the progression to dementia.
    Alzheimers Dement. 2017;13:644-653.
    PubMed     Abstract available


  342. BRENOWITZ WD, Hubbard RA, Keene CD, Hawes SE, et al
    Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample.
    Alzheimers Dement. 2017;13:654-662.
    PubMed     Abstract available


  343. SCHELLE J, Hasler LM, Gopfert JC, Joos TO, et al
    Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition.
    Alzheimers Dement. 2017;13:701-709.
    PubMed     Abstract available


    May 2017
  344. BROWN BM, Sohrabi HR, Taddei K, Gardener SL, et al
    Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2017 May 11. pii: S1552-5260(17)30147.
    PubMed     Abstract available


  345. WILLETTE AA, Webb JL, Lutz MW, Bendlin BB, et al
    Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.
    Alzheimers Dement. 2017 May 10. pii: S1552-5260(17)30148.
    PubMed     Abstract available


  346. FEART C, Helmer C, Merle B, Herrmann FR, et al
    Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer's disease in older adults.
    Alzheimers Dement. 2017 May 9. pii: S1552-5260(17)30138.
    PubMed     Abstract available


  347. BRUBAKER WD, Crane A, Johansson JU, Yen K, et al
    Peripheral complement interactions with amyloid beta peptides in Alzheimer's disease: Erythrocyte clearance of amyloid beta peptides.
    Alzheimers Dement. 2017 May 2. pii: S1552-5260(17)30149.
    PubMed     Abstract available


    April 2017
  348. CARMONA-IRAGUI M, Balasa M, Benejam B, Alcolea D, et al
    Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
    Alzheimers Dement. 2017 Apr 29. pii: S1552-5260(17)30146.
    PubMed     Abstract available


  349. CARRILLO MC, Fillit H, Ganguli M, Knopman D, et al
    Letter to the Editor re: Nexus of Cancer & Alzheimer's.
    Alzheimers Dement. 2017 Apr 19. pii: S1552-5260(17)30142.
    PubMed    


  350. SCHELTENS NME, Tijms BM, Koene T, Barkhof F, et al
    Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.
    Alzheimers Dement. 2017 Apr 17. pii: S1552-5260(17)30137.
    PubMed     Abstract available


    March 2017
  351. RITCHIE K, Carriere I, Su L, O'Brien JT, et al
    The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study.
    Alzheimers Dement. 2017 Mar 29. pii: S1552-5260(17)30093.
    PubMed     Abstract available


  352. NIELSEN RB, Egefjord L, Angleys H, Mouridsen K, et al
    Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 23. pii: S1552-5260(17)30092.
    PubMed     Abstract available


  353. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Alzheimers Dement. 2017 Mar 22. pii: S1552-5260(16)33124.
    PubMed     Abstract available


  354. ROCKWOOD K, Howlett SE, Hoffman D, Schindler R, et al
    Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30090.
    PubMed     Abstract available


  355. TOLEDO JB, Arnold M, Kastenmuller G, Chang R, et al
    Metabolic network failures in Alzheimer's disease-A biochemical road map.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30046.
    PubMed     Abstract available


  356. KARLAWISH J, Jack CR Jr, Rocca WA, Snyder HM, et al
    Alzheimer's disease: The next frontier-Special Report 2017.
    Alzheimers Dement. 2017 Mar 14. pii: S1552-5260(17)30091.
    PubMed     Abstract available


  357. KARAGEORGIOU E, Vossel KA
    Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications.
    Alzheimers Dement. 2017 Mar 13. pii: S1552-5260(17)30061.
    PubMed     Abstract available


  358. PASE MP, Himali JJ, Jacques PF, DeCarli C, et al
    Sugary beverage intake and preclinical Alzheimer's disease in the community.
    Alzheimers Dement. 2017 Mar 5. pii: S1552-5260(17)30050.
    PubMed     Abstract available


  359. BALDACCI F, Toschi N, Lista S, Zetterberg H, et al
    Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30047.
    PubMed     Abstract available


  360. BOSCO P, Redolfi A, Bocchetta M, Ferrari C, et al
    The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30045.
    PubMed     Abstract available


  361. WEINTRAUB S, Randolph C, Bain L, Hendrix JA, et al
    Is cognitive decline measurable in preclinical Alzheimer's disease?
    Alzheimers Dement. 2017;13:322-323.
    PubMed    


  362. HERUKKA SK, Simonsen AH, Andreasen N, Baldeiras I, et al
    Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
    Alzheimers Dement. 2017;13:285-295.
    PubMed     Abstract available


  363. SIMONSEN AH, Herukka SK, Andreasen N, Baldeiras I, et al
    Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.
    Alzheimers Dement. 2017;13:274-284.
    PubMed     Abstract available


  364. TON TGN, DeLeire T, May SG, Hou N, et al
    The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment.
    Alzheimers Dement. 2017;13:217-224.
    PubMed     Abstract available


    February 2017
  365. MORMINO EC, Papp KV, Rentz DM, Donohue MC, et al
    Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated beta-amyloid.
    Alzheimers Dement. 2017 Feb 27. pii: S1552-5260(17)30044.
    PubMed     Abstract available


  366. KIN WONG MW, Braidy N, Poljak A, Pickford R, et al
    Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30012.
    PubMed     Abstract available


  367. MUKHERJEE S, Russell JC, Carr DT, Burgess JD, et al
    Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30042.
    PubMed     Abstract available


  368. JIA J, Gauthier S, Pallotta S, Ji Y, et al
    Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 23. pii: S1552-5260(17)30011.
    PubMed     Abstract available


  369. JONSSON L, Lin PJ, Khachaturian AS
    Special topic section on health economics and public policy of Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 20. pii: S1552-5260(17)30085.
    PubMed    


  370. FARDO DW, Gibbons LE, Mukherjee S, Glymour MM, et al
    Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30018.
    PubMed     Abstract available


  371. TEICHMANN M, Epelbaum S, Samri D, Levy Nogueira M, et al
    Free and Cued Selective Reminding Test-accuracy for Alzheimer's and neurodegenerative disease differential diagnosis: A large-scale biomarker-characterized monocenter cohort study (ClinAD).
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30014.
    PubMed     Abstract available


  372. OBOUDIYAT C, Gefen T, Varelas E, Weintraub S, et al
    Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia.
    Alzheimers Dement. 2017 Feb 11. pii: S1552-5260(17)30010.
    PubMed     Abstract available


  373. EPELBAUM S, Genthon R, Cavedo E, Habert MO, et al
    Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.
    Alzheimers Dement. 2017 Feb 7. pii: S1552-5260(16)33123.
    PubMed     Abstract available


  374. JUN GR, Chung J, Mez J, Barber R, et al
    Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
    Alzheimers Dement. 2017 Feb 6. pii: S1552-5260(17)30003.
    PubMed     Abstract available


  375. SPOSATO LA, Ruiz Vargas E, Riccio PM, Toledo JB, et al
    Milder Alzheimer's disease pathology in heart failure and atrial fibrillation.
    Alzheimers Dement. 2017 Feb 4. pii: S1552-5260(16)33122.
    PubMed     Abstract available


  376. OVERK C, Masliah E
    Perspective on the calcium dyshomeostasis hypothesis in the pathogenesis of selective neuronal degeneration in animal models of Alzheimer's disease.
    Alzheimers Dement. 2017;13:183-185.
    PubMed    


    January 2017
  377. NESTOR SM, Misic B, Ramirez J, Zhao J, et al
    Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 27. pii: S1552-5260(16)33128.
    PubMed     Abstract available


  378. LLINAS R, Moreno H
    Perspective on calcium and Alzheimer disease.
    Alzheimers Dement. 2017 Jan 25. pii: S1552-5260(17)30008.
    PubMed    


  379. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 7. pii: S1552-5260(16)33125.
    PubMed     Abstract available


  380. ZHAO J, Zhu Y, Yang J, Li L, et al
    A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 6. pii: S1552-5260(16)33059.
    PubMed     Abstract available


  381. GUSTAVSSON A, Green C, Jones RW, Forstl H, et al
    Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 4. pii: S1552-5260(16)33126.
    PubMed     Abstract available



  382. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis.
    Alzheimers Dement. 2017 Jan 3. pii: S1552-5260(16)33127.
    PubMed     Abstract available


    December 2016
  383. DODGE HH, Zhu J, Woltjer R, Nelson PT, et al
    Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.
    Alzheimers Dement. 2016 Dec 22. pii: S1552-5260(16)33091.
    PubMed     Abstract available


  384. SNYDER HM, Ahles T, Calderwood S, Carrillo MC, et al
    Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies.
    Alzheimers Dement. 2016 Dec 17. pii: S1552-5260(16)33090.
    PubMed     Abstract available


  385. CARRASQUILLO MM, Allen M, Burgess JD, Wang X, et al
    A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
    Alzheimers Dement. 2016 Dec 8. pii: S1552-5260(16)33071.
    PubMed     Abstract available


  386. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.
    Alzheimers Dement. 2016 Dec 5. pii: S1552-5260(16)33072.
    PubMed     Abstract available


    November 2016
  387. CRONIN P, McCarthy MJ, Lim AS, Salmon DP, et al
    Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1.
    Alzheimers Dement. 2016 Nov 21. pii: S1552-5260(16)33058.
    PubMed     Abstract available


  388. O'BRYANT SE, Mielke MM, Rissman RA, Lista S, et al
    Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
    Alzheimers Dement. 2016 Nov 18. pii: S1552-5260(16)33056.
    PubMed     Abstract available


  389. SNYDER HM, Shineman DW, Friedman LG, Hendrix JA, et al
    Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.
    Alzheimers Dement. 2016;12:1177-1185.
    PubMed     Abstract available


  390. FARGO KN, Carrillo MC, Weiner MW, Potter WZ, et al
    The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Alzheimers Dement. 2016;12:1113-1115.
    PubMed    


    October 2016
  391. MASTROENI D, Khdour OM, Delvaux E, Nolz J, et al
    Nuclear but not mitochondrial-encoded OXPHOS genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.
    Alzheimers Dement. 2016 Oct 25. pii: S1552-5260(16)32932.
    PubMed     Abstract available


  392. MEZ J, Chung J, Jun G, Kriegel J, et al
    Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2016 Oct 19. pii: S1552-5260(16)32931.
    PubMed     Abstract available


  393. HAMLETT ED, Goetzl EJ, Ledreux A, Vasilevko V, et al
    Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.
    Alzheimers Dement. 2016 Oct 15. pii: S1552-5260(16)32892.
    PubMed     Abstract available


  394. LAM B, Khan A, Keith J, Rogaeva E, et al
    Characterizing familial corticobasal syndrome due to Alzheimer's pathology and PSEN1 mutations.
    Alzheimers Dement. 2016 Oct 12. pii: S1552-5260(16)32894.
    PubMed     Abstract available


  395. RITCHIE K, Ropacki M, Albala B, Harrison J, et al
    Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32902.
    PubMed     Abstract available


  396. MORTAMAIS M, Ash JA, Harrison J, Kaye J, et al
    Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32901.
    PubMed     Abstract available


    September 2016
  397. JACK CR, Wiste HJ, Weigand SD, Therneau TM, et al
    Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 30. pii: S1552-5260(16)32875.
    PubMed     Abstract available


  398. PEGUEROLES J, Vilaplana E, Montal V, Sampedro F, et al
    Longitudinal brain structural changes in preclinical Alzheimer disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32890.
    PubMed     Abstract available


  399. NORAMBUENA A, Wallrabe H, McMahon L, Silva A, et al
    mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32895.
    PubMed     Abstract available


  400. PROITSI P, Kim M, Whiley L, Simmons A, et al
    Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30022.
    PubMed     Abstract available


  401. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid-beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32896.
    PubMed     Abstract available


  402. NI R, Gillberg PG, Bogdanovic N, Viitanen M, et al
    Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30141.
    PubMed     Abstract available


  403. LEEUWIS AE, Benedictus MR, Kuijer JP, Binnewijzend MA, et al
    Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 27. pii: S1552-5260(16)32893.
    PubMed     Abstract available


  404. SNYDER HM, Asthana S, Bain L, Brinton R, et al
    Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.
    Alzheimers Dement. 2016 Sep 21. pii: S1552-5260(16)32874.
    PubMed     Abstract available


    April 2016
  405. LIM YY, Maruff P, Getter C, Snyder PJ, et al
    Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.
    Alzheimers Dement. 2016;12:454-8.
    PubMed     Abstract available


  406. CRANE PK, Gibbons LE, McCurry SM, McCormick W, et al
    Importance of home study visit capacity in dementia studies.
    Alzheimers Dement. 2016;12:419-26.
    PubMed     Abstract available


    February 2016
  407. VERLINDEN VJ, van der Geest JN, de Bruijn RF, Hofman A, et al
    Trajectories of decline in cognition and daily functioning in preclinical dementia.
    Alzheimers Dement. 2016;12:144-53.
    PubMed     Abstract available


  408. TIWARI MK, Kepp KP
    beta-Amyloid pathogenesis: Chemical properties versus cellular levels.
    Alzheimers Dement. 2016;12:184-94.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: